Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jixing Gong

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Small (Weinheim an Der Bergstrasse, Germany)|September 11, 2022
Micropatterned Hydrogels with Highly Ordered Cellulose Nanocrystals for Visually Monitoring CardiomyocytesJunmei Wang, Qian Liu, Jixing Gong, et al.
Fundamental Research|April 13, 2026
Discovery of Zidovudine as a cardiomyocyte protectant for doxorubicin-induced toxicity through high-throughput phenotypic drug screeningHe Xu, Hao You, Jixing Gong, et al.
Cellular and Molecular Life Sciences : CMLS|February 17, 2026
MYBPC3 (c.194 C > T) mutation-mediated RyR2 dysfunction contributes to pathogenic phenotypes of DCM revealed by HiPSC modelingManting Xie, Bingbing Xie, Liang Huang, et al.
Materials Horizons|July 31, 2024
Biogenic derived nanoparticles modulate mitochondrial function in cardiomyocytesXiaolan Zheng, Tianyou Wang, Jixing Gong, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|September 2, 2022
Investigating and Resolving Cardiotoxicity Induced by COVID-19 Treatments using Human Pluripotent Stem Cell-Derived Cardiomyocytes and Engineered Heart TissuesHe Xu, Ge Liu, Jixing Gong, et al.
Nature Communications|September 12, 2024
Engineered model of heart tissue repair for exploring fibrotic processes and therapeutic interventionsPengcheng Yang, Lihang Zhu, Shiya Wang, et al.
NPJ Regenerative Medicine|March 5, 2026
Single-cell chromatin accessibility landscape of cardiac non-myocytes identifies tissue repair program during heart regenerationZihao Chen, Yage Nie, Liying Huang, et al.
Communications Biology|September 2, 2022
Spike-based adenovirus vectored COVID-19 vaccine does not aggravate heart damage after ischemic injury in miceShanshan Gu, Zhongyan Chen, Xiangfu Meng, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Small (Weinheim an Der Bergstrasse, Germany)|September 11, 2022
Micropatterned Hydrogels with Highly Ordered Cellulose Nanocrystals for Visually Monitoring CardiomyocytesJunmei Wang, Qian Liu, Jixing Gong, et al.
Fundamental Research|April 13, 2026
Discovery of Zidovudine as a cardiomyocyte protectant for doxorubicin-induced toxicity through high-throughput phenotypic drug screeningHe Xu, Hao You, Jixing Gong, et al.
Cellular and Molecular Life Sciences : CMLS|February 17, 2026
MYBPC3 (c.194 C > T) mutation-mediated RyR2 dysfunction contributes to pathogenic phenotypes of DCM revealed by HiPSC modelingManting Xie, Bingbing Xie, Liang Huang, et al.
Materials Horizons|July 31, 2024
Biogenic derived nanoparticles modulate mitochondrial function in cardiomyocytesXiaolan Zheng, Tianyou Wang, Jixing Gong, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|September 2, 2022
Investigating and Resolving Cardiotoxicity Induced by COVID-19 Treatments using Human Pluripotent Stem Cell-Derived Cardiomyocytes and Engineered Heart TissuesHe Xu, Ge Liu, Jixing Gong, et al.
Nature Communications|September 12, 2024
Engineered model of heart tissue repair for exploring fibrotic processes and therapeutic interventionsPengcheng Yang, Lihang Zhu, Shiya Wang, et al.
NPJ Regenerative Medicine|March 5, 2026
Single-cell chromatin accessibility landscape of cardiac non-myocytes identifies tissue repair program during heart regenerationZihao Chen, Yage Nie, Liying Huang, et al.
Communications Biology|September 2, 2022
Spike-based adenovirus vectored COVID-19 vaccine does not aggravate heart damage after ischemic injury in miceShanshan Gu, Zhongyan Chen, Xiangfu Meng, et al.
Pageof 1